Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Icosavax Inc.

United States 1930 Boren Avenue Suite 1000, 98101-1406, United States

About the sponsor

Icosavax Inc. focuses on vaccine research for respiratory syncytial virus and human metapneumovirus, with clinical interest in preventing lower respiratory tract disease in older adults.

  • RSV prevention
  • hMPV prevention
  • VLP vaccine development

The company’s clinical activity is centered on adult immunization, particularly in populations aged 60 years and older.

About Specializations

Icosavax Inc. runs clinical trials in conditions such as Metapneumovirus infection, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Metapneumovirus infection

Not yet recruiting

Study on the Effectiveness and Safety of IVX-A12 Vaccine for Preventing Respiratory Infections in Adults Aged 60 and Older

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Human metapneumovirus, virus-like protein
  • Sponsor:AstraZeneca AB

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.